Private Trust Co. NA Sells 51 Shares of Humana Inc. $HUM

Private Trust Co. NA reduced its stake in shares of Humana Inc. (NYSE:HUM) by 8.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 559 shares of the insurance provider’s stock after selling 51 shares during the quarter. Private Trust Co. NA’s holdings in Humana were worth $137,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Cary Street Partners Investment Advisory LLC boosted its stake in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Zions Bancorporation National Association UT bought a new position in Humana in the first quarter worth about $37,000. Ransom Advisory Ltd purchased a new stake in Humana in the first quarter worth about $66,000. Transamerica Financial Advisors LLC boosted its position in Humana by 1,027.6% during the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock valued at $87,000 after acquiring an additional 298 shares in the last quarter. Finally, Tower View Wealth Management LLC purchased a new position in shares of Humana during the 2nd quarter worth approximately $88,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Trading Down 2.5%

Shares of NYSE:HUM opened at $287.97 on Thursday. The stock has a 50 day moving average of $281.38 and a 200 day moving average of $258.81. The company has a market cap of $34.63 billion, a PE ratio of 22.10, a price-to-earnings-growth ratio of 1.73 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the prior year, the business earned $6.96 earnings per share. Humana’s revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s dividend payout ratio is presently 27.17%.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research analyst reports. Mizuho raised their target price on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Wolfe Research boosted their target price on shares of Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a report on Monday, October 6th. Wells Fargo & Company upped their target price on shares of Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Truist Financial set a $300.00 price objective on Humana in a research report on Tuesday, October 14th. Finally, Wall Street Zen downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $297.58.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.